Similar articles

• Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women.

  Ursin G, London S, Stanczyk FZ, Gentzschein E, Paganini-Hill A, Ross RK, Pike MC. Ursin G, et al. J Natl Cancer Inst. 1999 Jun 16;91(12):1067-72. doi: 10.1093/jnci/91.12.1067. J Natl Cancer Inst. 1999. PMID: 10379970
• A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer.

  Ursin G, London S, Stanczyk FZ, Gentzschein E, Paganini-Hill A, Ross RK, Pike MC. Ursin G, et al. Environ Health Perspect. 1997 Apr;105 Suppl 3(Suppl 3):601-5. doi: 10.1289/ehp.97105s3601. Environ Health Perspect. 1997. PMID: 9168002 Free PMC article.
• A new ELISA kit for measuring urinary 2-hydroxyestrone, 16alpha-hydroxyestrone, and their ratio: reproducibility, validity, and assay performance after freeze-thaw cycling and preservation by boric acid.

  Falk RT, Rossi SC, Fears TR, Sepkovic DW, Migella A, Adlercreutz H, Donaldson J, Bradlow HL, Ziegler RG. Falk RT, et al. Cancer Epidemiol Biomarkers Prev. 2000 Jan;9(1):81-7. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 10667467
• Urinary estrogen metabolites and prostate cancer: a case-control study and meta-analysis.

  Barba M, Yang L, Schünemann HJ, Sperati F, Grioni S, Stranges S, Westerlind KC, Blandino G, Gallucci M, Lauria R, Malorni L, Muti P. Barba M, et al. J Exp Clin Cancer Res. 2009 Oct 8;28(1):135. doi: 10.1186/1756-9966-28-135. J Exp Clin Cancer Res. 2009. PMID: 19814782 Free PMC article.
• [Estrogen-dependent neoplasia - what is the significance of estradiol metabolites].

  Mueck AO, Seeger H, Lippert TH. Mueck AO, et al. Zentralbl Gynakol. 2003 Nov;125(11):458-66. doi: 10.1055/s-2003-44575. Zentralbl Gynakol. 2003. PMID: 14634875 Review. German.